[{"data":1,"prerenderedAt":181},["ShallowReactive",2],{"drug-ciprofloxacin-eye":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":23,"regimens":38,"contraindications":76,"warnings":86,"renal":94,"monitoring":95,"interactions":96,"review":97,"examples":100,"atc":105,"iran":107,"links":127,"populations":142,"usApproval":176},"ciprofloxacin-eye",1,{"fa":7,"en":8},"قطره چشمی سیپروفلوکساسین","Ciprofloxacin eye drops","sensory-organs",{"fa":11,"en":12},"فلوروکینولون موضعی چشم","Topical ophthalmic fluoroquinolone",[14],{"name":15,"market":16},"Ciloxan","US",[18,19,20,21,22],"ciloxan","سیلوکسان","سیپروفلوکساسین","قطره چشم","زخم قرنیه",[24],{"id":25,"form":26,"route":27,"label":28,"concentration":29,"markets":31,"refs":32},"sol-0-3","eye-drops","ophthalmic","0.3% (3 mg\u002FmL) eye drops",{"amount":5,"unit":30,"perUnit":30},"drop",[16],[33,36],{"source":34,"section":35},"fda-ciprofloxacin-eye","Description",{"source":34,"section":37},"How Supplied",[39,61],{"id":40,"disease":41,"label":42,"population":45,"type":46,"unit":30,"dose":47,"refs":50,"durationDays":53,"notes":54},"conj-d1-2","bacterial-conjunctivitis",{"fa":43,"en":44},"کونژنکتیویت باکتریایی — روز ۱ و ۲: ۱ تا ۲ قطره هر ۲ ساعت در بیداری","Bacterial conjunctivitis — days 1–2: 1–2 drops every 2 hours while awake",{},"fixed",{"perDose":5,"perDoseMax":48,"dosesPerDay":49},2,8,[51],{"source":34,"section":52},"Dosage and Administration",{"min":48,"max":48},[55],{"text":56,"refs":59},{"fa":57,"en":58},"روز ۳ تا ۷: ۱ تا ۲ قطره هر ۴ ساعت در بیداری. تعداد ۸ نوبت در روز را Doz با فرض ۱۶ ساعت بیداری حساب کرده؛ برچسب فقط «هر ۲ ساعت در بیداری» می‌گوید.","Days 3–7: 1–2 drops every 4 hours while awake. The 8 doses\u002Fday is a Doz estimate assuming 16 waking hours; the label says only \"every two hours while awake\".",[60],{"source":34,"section":52},{"id":62,"disease":63,"label":64,"population":67,"type":68,"unit":69,"dose":70,"refs":74},"ulcer","corneal-ulcer",{"fa":65,"en":66},"زخم قرنیه — طبق برنامه برچسب","Corneal ulcer — per label schedule",{},"notCalculated","mg",{"reason":71},{"fa":72,"en":73},"روز ۱: ۲ قطره هر ۱۵ دقیقه به مدت ۶ ساعت، سپس هر ۳۰ دقیقه؛ روز ۲: ۲ قطره هر ساعت؛ روز ۳ تا ۱۴: ۲ قطره هر ۴ ساعت. زیر نظر چشم‌پزشک.","Day 1: 2 drops every 15 min for 6 h, then every 30 min; day 2: 2 drops hourly; days 3–14: 2 drops every 4 h. Under ophthalmologist care.",[75],{"source":34,"section":52},[77],{"id":78,"severity":79,"text":80,"refs":83},"hyper","block",{"fa":81,"en":82},"حساسیت به سیپروفلوکساسین یا سایر کینولون‌ها.","Hypersensitivity to ciprofloxacin or other quinolones.",[84],{"source":34,"section":85},"Contraindications",[87],{"text":88,"refs":91},{"fa":89,"en":90},"بی‌خطری و اثربخشی در همه سنین، از جمله نوزادان، ثابت شده است.","Safety and effectiveness established in all ages, including neonates.",[92],{"source":34,"section":93},"Pediatric Use",[],[],[],{"status":98,"reviewer":99,"date":99},"unverified",null,[101],{"regimen":40,"formulation":25,"input":102,"expect":104},{"ageYears":5,"weightKg":103},10,{"perDose":5,"upperPerDose":48},[106],"S01AE03",{"status":108,"forms":109,"refs":122},"registered",[110,114,118],{"code":111,"en":112,"fa":113},"00297","CIPROFLOXACIN HCL 0.3% OPH DROP","قطره چشمی سیپروفلوکساسین هیدروکلراید ۰٫۳ درصد",{"code":115,"en":116,"fa":117},"17340","CIPROFLOXACIN HCL 0.3% OPH OINT","پماد سیپروفلوکساسین هیدروکلراید ۰٫۳ درصد",{"code":119,"en":120,"fa":121},"52528","CIPROFLOXACIN SOLUTION, DROPS OPHTHALMIC 0.3 % 5 mL","قطره چشمی سیپروفلوکساسین ۰٫۳ درصد ۵ میلی‌لیتر",[123],{"source":124,"section":125,"url":126},"darooyab-generic","G-4565\u002FCiprofloxacin-Ophthalmic","https:\u002F\u002Fwww.darooyab.ir\u002FG-4565\u002FCiprofloxacin-Ophthalmic",[128,132,136,139],{"kind":129,"url":130,"label":131},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=019992","NDA019992",{"kind":133,"url":134,"label":135},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=1ac4540c-d0f7-70bc-e063-6394a90a0f7a","FDA Cipro eye drops",{"kind":137,"url":138,"label":106},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01AE03",{"kind":140,"url":126,"label":141},"darooyab","Ciprofloxacin-Ophthalmic",{"pregnancy":143,"lactation":152,"pediatric":160,"geriatric":167},{"level":144,"text":145,"quote":148,"refs":149},"caution",{"fa":146,"en":147},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Ciprofloxacin ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.",[150],{"source":34,"section":151},"Pregnancy",{"level":144,"text":153,"quote":156,"refs":157},{"fa":154,"en":155},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Caution should be exercised when ciprofloxacin ophthalmic solution is administered to a nursing mother.",[158],{"source":34,"section":159},"Nursing Mothers",{"level":144,"text":161,"quote":164,"refs":165},{"fa":162,"en":163},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","The safety and effectiveness of ciprofloxacin ophthalmic solution 0.3% have been established in all ages.",[166],{"source":34,"section":93},{"level":168,"text":169,"quote":172,"refs":173},"ok",{"fa":170,"en":171},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety or effectiveness have been observed between elderly and younger patients.",[174],{"source":34,"section":175},"Geriatric Use",{"kind":177,"refs":178,"id":131},"NDA authorized generic",[179],{"source":34,"section":180},"SPL approval \u002F marketing category",1792191881653]